Literature DB >> 24440776

Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.

Shinya Sonobe1, Miki Fujimura2, Kuniyasu Niizuma1, Yasuo Nishijima1, Akira Ito1, Hiroaki Shimizu1, Atsuo Kikuchi3, Natsuko Arai-Ichinoi3, Shigeo Kure3, Teiji Tominaga1.   

Abstract

Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with unknown etiology. Recent genome-wide and locus-specific association studies identified RNF213 as an important MMD susceptibility gene. However, the exact mechanism by which an abnormality in RNF213 leads to MMD is unknown. To evaluate the role of RNF213 in the etiology of MMD, we generated RNF213-deficient mice (RNF213-/-) by deleting exon 32 of RNF213 by the Cre-lox system, and investigated whether they developed MMD. The temporal profile of cervical/intracranial arteries was evaluated by 9.4-T magnetic resonance angiography (MRA). The anatomy of the circle of Willis was analyzed by a trans-cardiac injection of carbon black dye. The common carotid arteries (CCA) were sectioned and the arterial wall thickness/thinness was evaluated by Elastica-Masson staining before and after CCA ligation, which selectively induced vascular hyperplasia. As a result, RNF213-/- grew normally, and no significant difference was observed in MRA findings, the anatomy of the circle of Willis, or vascular wall thickness/thinness between RNF-/- and wild-type littermates (Wt.) under normal conditions until 64 weeks of age. However, Elastica-Masson staining demonstrated that both the intima and medial layer were significantly thinner after CCA ligation in RNF213-/- than in Wt. after 14 days (P<0.01). In conclusion, mice lacking the RNF213 gene did not spontaneously develop MMD, indicating that a functional loss of RNF213 did not sufficiently induce MMD. Suppression of vascular remodeling in RNF213-/- requires further examination to clarify the role of RNF213.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Homologous recombination; Knockout mice; Moyamoya disease; RNF213

Mesh:

Substances:

Year:  2014        PMID: 24440776     DOI: 10.1016/j.brainres.2014.01.011

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  37 in total

1.  Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant.

Authors:  Tamar Harel; Jennifer E Posey; Brett H Graham; Magdalena Walkiewicz; Yaping Yang; Seema R Lalani; John W Belmont
Journal:  Am J Med Genet A       Date:  2015-07-21       Impact factor: 2.802

Review 2.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

Review 3.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

4.  RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population.

Authors:  Sirui Zhou; Amirthagowri Ambalavanan; Daniel Rochefort; Pingxing Xie; Cynthia V Bourassa; Pascale Hince; Alexandre Dionne-Laporte; Dan Spiegelman; Ziv Gan-Or; Cathy Mirarchi; Vessela Zaharieva; Nicolas Dupré; Hatasu Kobayashi; Toshiaki Hitomi; Kouji Harada; Akio Koizumi; Lan Xiong; Patrick A Dion; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

5.  Genome-Wide Association Study of Intracranial Artery Stenosis Followed by Phenome-Wide Association Study.

Authors:  Shogo Dofuku; Kyuto Sonehara; Satoru Miyawaki; Saori Sakaue; Hideaki Imai; Masahiro Shimizu; Hiroki Hongo; Yuki Shinya; Kenta Ohara; Yu Teranishi; Atsushi Okano; Hideaki Ono; Hirofumi Nakatomi; Akira Teraoka; Kenichi Yamamoto; Yuichi Maeda; Takuro Nii; Toshihiro Kishikawa; Ken Suzuki; Jun Hirata; Meiko Takahashi; Koichi Matsuda; Atsushi Kumanogoh; Fumihiko Matsuda; Yukinori Okada; Nobuhito Saito
Journal:  Transl Stroke Res       Date:  2022-06-14       Impact factor: 6.829

6.  RNF213 p.Arg4810Lys Heterozygosity in Moyamoya Disease Indicates Early Onset and Bilateral Cerebrovascular Events.

Authors:  Daiichiro Ishigami; Satoru Miyawaki; Hideaki Imai; Masahiro Shimizu; Hiroki Hongo; Shogo Dofuku; Kenta Ohara; Yu Teranishi; Daisuke Shimada; Satoshi Koizumi; Hideaki Ono; Yudai Hirano; Masafumi Segawa; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Transl Stroke Res       Date:  2021-10-30       Impact factor: 6.829

Review 7.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

8.  Significance of cyclooxygenase-2 elevation in middle cerebral artery for patients with hemorrhagic moyamoya disease.

Authors:  Jian-Jian Zhang; Zhong-Wei Xiong; Sheng Wang; Shou-Jia Sun; Hao Wang; Xiao-Lin Wu; Long Wang; Hua-Qiu Zhang; Chao You; Yu Wang; Jin-Cao Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-04-13

Review 9.  Diagnosis of moyamoya disease: international standard and regional differences.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 10.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.